» Articles » PMID: 28387715

Prp19 Arrests Cell Cycle Via Cdc5L in Hepatocellular Carcinoma Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Apr 8
PMID 28387715
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Pre-mRNA processing factor 19 (Prp19) is involved in many cellular events including pre-mRNA processing and DNA damage response. Recently, it has been identified as a candidate oncogene in hepatocellular carcinoma (HCC). However, the role of Prp19 in tumor biology is still elusive. Here, we reported that Prp19 arrested cell cycle in HCC cells via regulating G2/M transition. Mechanistic insights revealed that silencing Prp19 inhibited the expression of cell division cycle 5-like (Cdc5L) via repressing the translation of Cdc5L mRNA and facilitating lysosome-mediated degradation of Cdc5L in HCC cells. Furthermore, we found that silencing Prp19 induced cell cycle arrest could be partially resumed by overexpressing Cdc5L. This work implied that Prp19 participated in mitotic progression and thus could be a promising therapeutic target of HCC.

Citing Articles

Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination.

Qiu S, Wang F, Gao X, Guan W, Dai T, Yin L Int J Biol Sci. 2025; 21(4):1603-1618.

PMID: 39990666 PMC: 11844288. DOI: 10.7150/ijbs.101962.


Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis.

Liu Z, Lin X, Zhang D, Guo D, Tang W, Yu X Adv Sci (Weinh). 2024; 11(46):e2407517.

PMID: 39422063 PMC: 11633487. DOI: 10.1002/advs.202407517.


YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1.

Kwon J, Kim S Med Oncol. 2024; 41(11):280.

PMID: 39400789 DOI: 10.1007/s12032-024-02516-0.


DNA and RNA Binding Proteins: From Motifs to Roles in Cancer.

Bonczek O, Wang L, Vadivel Gnanasundram S, Chen S, Haronikova L, Zavadil-Kokas F Int J Mol Sci. 2022; 23(16).

PMID: 36012592 PMC: 9408909. DOI: 10.3390/ijms23169329.


The Interplay of Cohesin and RNA Processing Factors: The Impact of Their Alterations on Genome Stability.

Osadska M, Selicky T, Kretova M, Jurcik J, Sivakova B, Cipakova I Int J Mol Sci. 2022; 23(7).

PMID: 35409298 PMC: 8999970. DOI: 10.3390/ijms23073939.


References
1.
Chanarat S, Strasser K . Splicing and beyond: the many faces of the Prp19 complex. Biochim Biophys Acta. 2013; 1833(10):2126-34. DOI: 10.1016/j.bbamcr.2013.05.023. View

2.
Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang W . Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J Clin Invest. 2012; 122(7):2554-66. PMC: 3386807. DOI: 10.1172/JCI58488. View

3.
Asghar U, Witkiewicz A, Turner N, Knudsen E . The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015; 14(2):130-46. PMC: 4480421. DOI: 10.1038/nrd4504. View

4.
Wan L, Huang J . The PSO4 protein complex associates with replication protein A (RPA) and modulates the activation of ataxia telangiectasia-mutated and Rad3-related (ATR). J Biol Chem. 2014; 289(10):6619-6626. PMC: 3945324. DOI: 10.1074/jbc.M113.543439. View

5.
Merle P, Trepo C . Molecular mechanisms underlying hepatocellular carcinoma. Viruses. 2011; 1(3):852-72. PMC: 3185529. DOI: 10.3390/v1030852. View